Regeneron Earnings Top Analysts' Estimates as Drug Sales Rise

... $2.68 on average, according to estimates compiled by Bloomberg. Revenue increased 39 percent to $870 million, the Tarrytown, New York-based company said Thursday in a statement. Analysts had predicted $824 million. U.S. sales of Eylea, Regeneron's ...
http://ift.tt/1GQZfM7